Wayne Casimiro, head coach of the Belize Women’s National Team (BWNT), has officially completed the FIFA Coach Educators’ Diploma, joining fellow Belizean educator Philip Marin in earning one of the ...

Long held beliefs about the chronology and level of sophistication of early North American civilizations have been called into question by the recent discovery of what some consider to be America's ...

Roberto Fernandez was just one class shy from graduating when he stepped away from FIU in 1975 to focus on his growing accounting business. Now, 50 years later, he has returned to finish what he ...

The U.S. Air Force is buying two Boeing 747-8is from Lufthansa for training and spares as part of the delayed program to replace the current VC-25A “Air Force One” fleet, the service has confirmed to ...

Boeing Co.’s troubled Air Force One program in San Antonio may deliver a new presidential jet a year earlier than it estimated — but still four years behind its original contract date. After approving ...

One UI 8.5 beta, based on Android 16, is now live for the Galaxy S25 series in select regions. Join via the Samsung Members app and download the 4GB update to try new Photo Assist upgrades, smarter ...

Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

Samsung has officially kicked off its One UI 8.5 beta program, and it brings several new features that enhance productivity, privacy and performance. Photo Assist now allows for unlimited image ...

SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...